rs2072450

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001134407.3(GRIN2A):​c.2168+409G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0966 in 152,176 control chromosomes in the GnomAD database, including 890 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.097 ( 890 hom., cov: 32)

Consequence

GRIN2A
NM_001134407.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.209

Publications

4 publications found
Variant links:
Genes affected
GRIN2A (HGNC:4585): (glutamate ionotropic receptor NMDA type subunit 2A) This gene encodes a member of the glutamate-gated ion channel protein family. The encoded protein is an N-methyl-D-aspartate (NMDA) receptor subunit. NMDA receptors are both ligand-gated and voltage-dependent, and are involved in long-term potentiation, an activity-dependent increase in the efficiency of synaptic transmission thought to underlie certain kinds of memory and learning. These receptors are permeable to calcium ions, and activation results in a calcium influx into post-synaptic cells, which results in the activation of several signaling cascades. Disruption of this gene is associated with focal epilepsy and speech disorder with or without cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
GRIN2A Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Landau-Kleffner syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • continuous spikes and waves during sleep
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • rolandic epilepsy-speech dyspraxia syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • self-limited epilepsy with centrotemporal spikes
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.154 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001134407.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIN2A
NM_001134407.3
MANE Select
c.2168+409G>T
intron
N/ANP_001127879.1
GRIN2A
NM_000833.5
c.2168+409G>T
intron
N/ANP_000824.1
GRIN2A
NM_001134408.2
c.2168+409G>T
intron
N/ANP_001127880.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIN2A
ENST00000330684.4
TSL:1 MANE Select
c.2168+409G>T
intron
N/AENSP00000332549.3
GRIN2A
ENST00000396573.6
TSL:1
c.2168+409G>T
intron
N/AENSP00000379818.2
GRIN2A
ENST00000562109.5
TSL:1
c.2168+409G>T
intron
N/AENSP00000454998.1

Frequencies

GnomAD3 genomes
AF:
0.0967
AC:
14709
AN:
152058
Hom.:
890
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0292
Gnomad AMI
AF:
0.0297
Gnomad AMR
AF:
0.0996
Gnomad ASJ
AF:
0.171
Gnomad EAS
AF:
0.162
Gnomad SAS
AF:
0.124
Gnomad FIN
AF:
0.0655
Gnomad MID
AF:
0.123
Gnomad NFE
AF:
0.132
Gnomad OTH
AF:
0.0998
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0966
AC:
14707
AN:
152176
Hom.:
890
Cov.:
32
AF XY:
0.0936
AC XY:
6966
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.0291
AC:
1210
AN:
41534
American (AMR)
AF:
0.0995
AC:
1521
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.171
AC:
592
AN:
3468
East Asian (EAS)
AF:
0.163
AC:
841
AN:
5168
South Asian (SAS)
AF:
0.125
AC:
604
AN:
4824
European-Finnish (FIN)
AF:
0.0655
AC:
694
AN:
10594
Middle Eastern (MID)
AF:
0.119
AC:
35
AN:
294
European-Non Finnish (NFE)
AF:
0.132
AC:
8976
AN:
67982
Other (OTH)
AF:
0.0978
AC:
207
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
678
1356
2034
2712
3390
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
178
356
534
712
890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.108
Hom.:
130
Bravo
AF:
0.0944
Asia WGS
AF:
0.135
AC:
472
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.49
DANN
Benign
0.51
PhyloP100
-0.21
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2072450; hg19: chr16-9915712; API